Table 1.
Characteristics of 475 patients with Strongyloides serodiagnostic testing
| Characteristic | Total N = 475 N (%) | Seropositive N = 78 N (%) |
|---|---|---|
| Age (years) median | 65 | 54 |
| Range | 12–104 | 27–99 |
| Female | 260 (55) | 19 (24) |
| Male | 215 (45) | 59 (76) |
| Race/ethnicity‡ | ||
| Micronesian | 151 (32) | 46 (30) |
| Filipino | 69 (15) | 9 (13) |
| Asian* | 69 (15) | 2 (3) |
| Polynesian† | 53 (11) | 14 (26) |
| White | 44 (9) | 3 (7) |
| Part-Hawaiian | 41 (9) | 1 (2) |
| Southeast Asian | 18 (4) | 2 (11) |
| Okinawan | 12 (3) | 1 (8) |
| Other/unspecified | 18 (4) | 0 |
| Immunosuppressed | ||
| Corticosteroids | 4 (5) | |
| Chemotherapy + steroid | 3 (4) | |
| Methotrexate | 2 (3) | |
| HTLV-1, N positive/N tested | 0/4 | |
| HIV, N positive/N tested | 0/8 | |
HIV = human immunodeficiency virus; HTLV = human T-lymphotrophic virus.
*
Chinese, Japanese, and Korean.
†
Samoan and Tongan.
‡
Presented as row percentages for seropositive patients to show antibody prevalence within race/ethnic groups.